Publications 2015, 3(1), 17-26; doi:10.3390/publications3010017
Persistent Citation of the Only Published Randomised Controlled Trial of Omega-3 Supplementation in Chronic Obstructive Pulmonary Disease Six Years after Its Retraction
Ashley S. Fulton 1,2,†, Alison M. Coates 1,2,†
, Marie T. Williams 2,3,†, Peter R.C. Howe 2,4,† and Alison M. Hill 2,5,†,*
, Marie T. Williams 2,3,†, Peter R.C. Howe 2,4,† and Alison M. Hill 2,5,†,*
1
School of Health Sciences, University of South Australia, Adelaide, SA 5001, Australia
2
Alliance for Research in Exercise, Nutrition and Activity (ARENA), Sansom Institute for Health Research, Division of Health Sciences, University of South Australia, Adelaide, SA 5001, Australia
3
School of Population Health, University of South Australia, Adelaide, SA 5001, Australia
4
Clinical Nutrition Research Centre, School of Biomedical Sciences & Pharmacy, University of Newcastle, University Drive, Callaghan NSW 2308, Australia
5
School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, SA 5001, Australia
†
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: R. Grant Steen
Received: 11 November 2014 / Accepted: 26 January 2015 / Published: 11 February 2015
Abstract
Scientific articles are retracted infrequently, yet have the potential to influence the scientific literature for years. The only randomised controlled trial to explore the effects of omega-3 polyunsaturated fatty acids in people with chronic obstructive pulmonary disease was retracted in 2008 due to falsified data. The objective of this research was to determine the frequency and nature of citations of this retracted paper. Web of Science and Google Scholar were used to determine the number of times the retracted article was cited. Citations were classified as either “retraction acknowledged” or “retraction not acknowledged”. The search was conducted on 6 August 2013 and updated on 25 March 2014. Results: The search resulted in 76 citations, of which 24 occurred prior to the retraction of the article. Of the 52 citations occurring after the retraction, only two acknowledged the retraction. Of the citations not acknowledging the retraction, 20 referred to specific data and 30 cited the reference in passing. This retracted article continues to be cited by authors, suggesting that information about the retraction was unsuccessfully communicated to the scientific community. Continual citation of retracted literature has the potential to bias a field of research and potentially misinform end-users. View Full-TextKeywords:
COPD; omega-3; retracted literature
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Fulton, A.S.; Coates, A.M.; Williams, M.T.; Howe, P.R.; Hill, A.M. Persistent Citation of the Only Published Randomised Controlled Trial of Omega-3 Supplementation in Chronic Obstructive Pulmonary Disease Six Years after Its Retraction. Publications 2015, 3, 17-26.
Related Articles
Article Metrics
Comments
[Return to top]
Publications
EISSN 2304-6775
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert